eg 626 has been researched along with Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burg, J; Gaudiani, VA; Jamieson, SW; Kosek, JC; Miller, DC | 1 |
| Yasunaga, K | 1 |
2 other study(ies) available for eg 626 and Thrombosis
| Article | Year |
|---|---|
Veno-venous allografts: patency, subendothelial proliferation, and the role of platelet-active agents.
Topics: Animals; Aspirin; Blood Platelets; Cell Division; Dipyridamole; Dogs; Female; Graft Survival; Male; Muscle, Smooth, Vascular; Phthalazines; Sulfinpyrazone; Thrombosis; Transplantation, Autologous; Transplantation, Homologous; Veins | 1983 |
[Inhibition of platelet aggregation by platelet inhibitory agents and its relation to their clinical effects].
Topics: Depression, Chemical; Dipyridamole; Dose-Response Relationship, Drug; Humans; Phthalazines; Platelet Aggregation; Pyridazines; Quinolines; Quinolones; Sulfinpyrazone; Thrombosis | 1979 |